project id: TCGA-HNSC; case submitter id: TCGA-QK-A8ZA; source center: 23; state: released; a260 a280 ratio: 1.94; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.89; rna integrity number: 9.4; age at index: 60; days to birth: -21979; days to death: 371; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Dead; year of birth: 1953; age at diagnosis: 21979; ajcc clinical m: MX; ajcc clinical n: N2b; ajcc clinical stage: Stage IVA; ajcc clinical t: T2; ajcc pathologic m: MX; ajcc pathologic n: N2b; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 368.0; icd 10 code: C10.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Oropharynx, NOS; synchronous malignancy: No; tissue or organ of origin: Oropharynx, NOS; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: yes; alcohol history: Yes; cigarettes per day: 0.821917808219178; pack years smoked: 15.0; is ffpe: false; composition: Not Reported; days to collection: 35; days to sample procurement: 0; initial weight: 30.0; portion submitter id: TCGA-QK-A8ZA-01A-11; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 25.0; percent tumor cells: 75.0; percent tumor nuclei: 75.0;